Drug Group Says Fed. Law Doesn't Bar $600M NY Opioid Levy Suit
New York's $600 million surcharge on pharmaceutical manufacturers and distributors isn't a tax, and therefore a suit against the law is not barred by the federal Tax Injunction Act, a pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article